Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.
Alexandre M, Marlin R, Prague M, Coleon S, Kahlaoui N, Cardinaud S, Naninck T, Delache B, Surenaud M, Galhaut M, Dereuddre-Bosquet N, Cavarelli M, Maisonnasse P, Centlivre M, Lacabaratz C, Wiedemann A, Zurawski S, Zurawski G, Schwartz O, Sanders RW, Le Grand R, Levy Y, Thiébaut R. Alexandre M, et al. Among authors: zurawski s. Elife. 2022 Jul 8;11:e75427. doi: 10.7554/eLife.75427. Elife. 2022. PMID: 35801637 Free PMC article.
Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen).
East C, Bass K, Mehta A, Rahimighazikalayed G, Zurawski S, Bottiglieri T. East C, et al. Among authors: zurawski s. Kidney Med. 2022 May 20;4(7):100483. doi: 10.1016/j.xkme.2022.100483. eCollection 2022 Jul. Kidney Med. 2022. PMID: 35801187 Free PMC article.
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
Coléon S, Wiedemann A, Surénaud M, Lacabaratz C, Hue S, Prague M, Cervantes-Gonzalez M, Wang Z, Ellis J, Sansoni A, Pierini C, Bardin Q, Fabregue M, Sharkaoui S, Hoest P, Dupaty L, Picard F, El Hajj M, Centlivre M, Ghosn J; French COVID Cohort Study Group; Thiébaut R, Cardinaud S, Malissen B, Zurawski G, Zarubica A, Zurawski SM, Godot V, Lévy Y. Coléon S, et al. Among authors: zurawski sm. EBioMedicine. 2022 Jun;80:104062. doi: 10.1016/j.ebiom.2022.104062. Epub 2022 May 17. EBioMedicine. 2022. PMID: 35594660 Free PMC article.
Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties.
Ceglia V, Zurawski S, Montes M, Bouteau A, Wang Z, Ellis J, Igyártó BZ, Lévy Y, Zurawski G. Ceglia V, et al. Among authors: zurawski s. J Immunol. 2021 Oct 15;207(8):2060-2076. doi: 10.4049/jimmunol.2000704. Epub 2021 Sep 22. J Immunol. 2021. PMID: 34551965 Free PMC article.
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
Marlin R, Godot V, Cardinaud S, Galhaut M, Coleon S, Zurawski S, Dereuddre-Bosquet N, Cavarelli M, Gallouët AS, Maisonnasse P, Dupaty L, Fenwick C, Naninck T, Lemaitre J, Gomez-Pacheco M, Kahlaoui N, Contreras V, Relouzat F, Fang RHT, Wang Z, Ellis J 3rd, Chapon C, Centlivre M, Wiedemann A, Lacabaratz C, Surenaud M, Szurgot I, Liljeström P, Planas D, Bruel T, Schwartz O, Werf SV, Pantaleo G, Prague M, Thiébaut R, Zurawski G, Lévy Y, Grand RL. Marlin R, et al. Among authors: zurawski s. Nat Commun. 2021 Sep 1;12(1):5215. doi: 10.1038/s41467-021-25382-0. Nat Commun. 2021. PMID: 34471122 Free PMC article.
108 results